↑ 薬物リストへ　← 戻る

Recombinant human interleukin-7    (DrugBank: Interleukin-7, Recombinant human interleukin-7)

1 disease
告示番号疾患名（ページ内リンク）臨床試験数
25進行性多巣性白質脳症3

25. 進行性多巣性白質脳症　［臨床試験数：23，薬物数：33（DrugBank：20），標的遺伝子数：7，標的パスウェイ数：36］
Searched query = "Progressive multifocal leukoencephalopathy", "PML", "Leukoencephalopathy, progressive multifocal"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
3 / 23 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1EUCTR2012-000725-41-GB
(EUCTR)		22/01/201304/09/2012A randomized, placebo controlled, multicenter phase IIb study of human recombinant Interleukin-7 (CYT107) in HIV-related Progressive Multifocal LeukoencephalopathyA randomized, placebo controlled, multicenter phase IIb study of human recombinant Interleukin-7 (CYT107) in HIV-related Progressive Multifocal Leukoencephalopathy. - INVICTUS HIV-infected patients with Progressive Multifocal Leukoencephalopathy
MedDRA version: 15.0;Level: PT;Classification code 10036807;Term: Progressive multifocal leukoencephalopathy;System Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Virus Diseases [C02]		Product Name: Recombinant human interleukin-7
Product Code: CYT107
INN or Proposed INN: N/A
Other descriptive name: Recombinant human interleukin-7		Cytheris S.A.NULLNot RecruitingFemale: yes
Male: yes		57Phase 2bUnited States;European Union;Spain;Italy;Switzerland;United Kingdom
2EUCTR2012-000725-41-ES
(EUCTR)		12/12/201214/09/2012A randomized, placebo controlled, multicenter phase IIb study of human recombinant Interleukin-7 (CYT107) in HIV-related Progressive Multifocal LeukoencephalopathyA randomized, placebo controlled, multicenter phase IIb study of human recombinant Interleukin-7 (CYT107) in HIV-related Progressive Multifocal Leukoencephalopathy. - INVICTUS HIV-infected patients with Progressive Multifocal Leukoencephalopathy
MedDRA version: 15.0;Level: PT;Classification code 10036807;Term: Progressive multifocal leukoencephalopathy;System Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Virus Diseases [C02]		Product Name: Recombinant human interleukin-7
Product Code: CYT107
INN or Proposed INN: N/A
Other descriptive name: Recombinant human interleukin-7		Cytheris S.A.NULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes		57Phase 2bUnited States;European Union;Spain;United Kingdom;Switzerland
3EUCTR2012-000725-41-IT
(EUCTR)		08/11/201211/12/2012A randomized, placebo controlled, multicenter phase IIb study of human recombinant Interleukin-7 (CYT107) in HIV-related Progressive Multifocal LeukoencephalopathyA randomized, placebo controlled, multicenter phase IIb study of human recombinant Interleukin-7 (CYT107) in HIV-related Progressive Multifocal Leukoencephalopathy - INVICTUS HIV-infected patients with Progressive Multifocal Leukoencephalopathy
MedDRA version: 14.1;Level: SOC;Classification code 10021881;Term: Infections and infestations;System Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Virus Diseases [C02]		Product Name: Recombinant human interleukin-7
Product Code: CYT107
Other descriptive name: Recombinant human interleukin-7		CYTHERISNULLNot RecruitingFemale: yes
Male: yes		57Phase 2bUnited States;Spain;United Kingdom;Switzerland;Italy